SESN2 and COVID-19: CD8+ T cell expression of Sestrin-2 was significantly higher in the COVID-19+ group (nMFI = 3.01 ± 1.92 versus 1.89 ± 0.77 in the control group, p = 0.034 Fig. 1B).